Nolpaza Enteric Tablets 20mg: Effective Relief for Heartburn and Acid Reflux
Experience lasting relief from the discomfort of heartburn and acid reflux with Nolpaza 20mg enteric tablets. This medication, containing pantoprazole sodium sesquihydrate, effectively reduces stomach acid production, providing long-lasting symptom relief.
What is Nolpaza?
Nolpaza is a prescription medication used to treat various conditions related to excess stomach acid, including:
- Symptomatic Gastroesophageal Reflux Disease (GERD): Nolpaza provides long-term treatment and helps prevent the recurrence of reflux esophagitis.
- Reflux Esophagitis: Nolpaza effectively heals and prevents the recurrence of inflammation in the esophagus caused by acid reflux.
- Prevention of Stomach and Duodenal Ulcers: Nolpaza is used to prevent ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk.
- Eradication of Helicobacter pylori (H. pylori): Nolpaza, in combination with appropriate antibiotics, effectively eliminates this bacterium, a common cause of peptic ulcers.
How Does Nolpaza Work?
Nolpaza works by blocking the production of stomach acid. The active ingredient, pantoprazole, specifically targets the proton pump in parietal cells, preventing the final step of acid synthesis. This results in a significant and lasting reduction in stomach acid levels, offering relief from heartburn and other symptoms.
Important Information:
- Liver Function: In patients with severe liver problems, regular monitoring of liver enzyme levels is crucial during treatment, especially with prolonged use.
- NSAID Use: Nolpaza dosage should be limited for ulcer prevention in patients taking NSAIDs long-term. Assess individual risk factors carefully.
- Warning Signs: If you experience any concerning symptoms like unintentional weight loss, persistent vomiting, difficulty swallowing, or blood in vomit/stool, contact your doctor immediately.
- Malignancy: Pantoprazole can relieve symptoms and potentially delay the diagnosis of stomach cancer. It’s important to exclude the possibility of malignancy before starting treatment.
- Vitamin B12 Absorption: Long-term use of Nolpaza may reduce vitamin B12 absorption. Consult your doctor if you are at risk or experience related symptoms.
- Hypomagnesemia: Prolonged use of PPIs like Nolpaza can cause low magnesium levels. Monitor your magnesium levels regularly if you are at risk or experience symptoms.
- Fracture Risk: Long-term use of high-dose PPIs may slightly increase the risk of fractures. Discuss this with your doctor and take steps to manage osteoporosis if needed.
- Pregnancy and Lactation: Nolpaza should not be used during pregnancy unless absolutely necessary. Breastfeeding should be stopped during treatment.
- Driving and Operating Machinery: Nolpaza may cause dizziness or visual disturbances. Avoid driving or operating machinery until you know how this medication affects you.
Dosage and Administration:
Nolpaza tablets should be swallowed whole with a small amount of liquid before meals. The recommended dosage depends on the specific condition being treated and is determined by your doctor.
Speak to your doctor or pharmacist for complete information on dosage, potential side effects, interactions, and contraindications. They can help you determine if Nolpaza is the right treatment option for you.
Order Nolpaza 20mg Enteric Tablets No. 14×1 Today and Begin Your Journey to Lasting Relief.
Disclaimer: This information is not a substitute for professional medical advice. Consult with your doctor or pharmacist for personalized guidance and treatment options.
| INN | PANTOPRAZOLE |
|---|---|
| The code | 46 073 |
| Side effects | Uncommon (≥ 1/1, 000 to <1/100) sleep disturbances headache, dizziness diarrhea, nausea, vomiting, bloating and flatulence, constipation, dry mouth, abdominal pain, discomfort elevated liver enzymes (transaminases, γ-GT) rash, exanthema, skin rash, itching fractures of the bones of the spine, hip and wrist asthenia, malaise and fatigue Rarely (from ≥ 1/10, 000 to <1/1, 000) agranulocytosis hypersensitivity reactions (including anaphylactic reactions and anaphylactic shock) hyperlipidemia, increased levels of triglycerides, cholesterol, changes in body weight, taste disturbance depression (and all exacerbations) visual disturbances, blurred vision increased bilirubin levels urticaria, Quincke's edema arthralgia, myalgia gynecomastia fever, peripheral edema Very rarely (<1/ 10, 000) thrombocytopenia, leukopenia, confusion (and all associated exacerbations) Not known (cannot be estimated from the available data): hyponatremia, hypomagnesemia hallucinations inations, confusion (especially in genetically predisposed patients, and exacerbation of these symptoms if they existed before treatment) hepatocellular damage, jaundice, hepatocellular insufficiency Stevens-Johnson syndrome, Lyell's syndrome, erythema multiforme, photosensitivity interstitial nephritis |
| Importer | IOOO Interfarmaks 223028 Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Star, 19a-5, room. 5-2 |
| Composition Means | active substance – pantoprazole sodium sesquihydrate 22.55 mg or 45.10 mg (equivalent to pantoprazole 20 mg or 40 mg, respectively), excipients: mannitol, crospovidone (type B), anhydrous sodium carbonate, sorbitol (E420), calcium stearate, composition enteric coating: hypromellose (2.4-3.6 mPas), povidone (K25), titanium dioxide (E171), iron oxide yellow (E172), propylene glycol, *methacrylic acid-ethyl acrylate copolymer (1:1) 30% dispersion, macrogol 6000, talc |
| Main Active Substances | pantoprazole sodium sesquihydrate 22.55 mg or 45.10 mg |
| Release Form | tablets |
| Application Gender | Any |
| Use during pregnancy and lactation | unknown |
| Contraindications | hypersensitivity to pantoprazole, substituted benzimidazoles or auxiliary components of the drug – combined use with atazanavir |
| Barcode | 3, 84E+12 |
| Indications Applications | For a dosage of 20 mg: Adults and adolescents from 12 years of age and older – symptomatic gastroesophageal reflux disease – for the long-term treatment and prevention of relapse of reflux esophagitis. Adults – prevention of erosive and ulcerative lesions of the stomach and duodenum caused by the use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at increased risk and in need of ongoing treatment with NSAIDs (See section "special instructions") For a dosage of 40 mg Adults and adolescents from 12 years and older – reflux esophagitis Adults – eradication of Helicobacter pylori (H. pylori) in combination with appropriate antibiotic therapy in patients with peptic ulcer associated with H. pylori – peptic ulcer of the stomach and duodenum – Zollinger-Ellison syndrome and other pathological hypersecretory states |
| trade line | Nolpaza |
| Trademark | KRKA |
| Manufacturer | Krka dd, Slovenia |
| Active substance | Pantoprazole |
| Dosage | 20mg |
Related products
Gastrointestinal Health
Gastrointestinal Health
Pharmaceutical technology Nifuroxazide suspension, 220 mg / 5 ml, 90 ml.